Biblio

Export 182 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is X  [Clear All Filters]
2017
C. Zhang, Zhang, Y., Shen, Y., Zhao, G., Xie, Z., and Dong, Y., “Anesthesia/Surgery Induces Cognitive Impairment in Female Alzheimer's Disease Transgenic Mice.”, J Alzheimers Dis, vol. 57, no. 2, pp. 505-518, 2017.
I. Maezawa, Zou, B., Di Lucente, J., Cao, W. S., Pascual, C., Weerasekara, S., Zhang, M., Xie, X. Simon, Hua, D. H., and Jin, L. - W., “The Anti-Amyloid-β and Neuroprotective Properties of a Novel Tricyclic Pyrone Molecule.”, J Alzheimers Dis, vol. 58, no. 2, pp. 559-574, 2017.
J. Yang, Zhang, R., Shi, C., Mao, C., Yang, Z., Suo, Z., Torp, R., and Xu, Y., “AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 157-169, 2017.
L. Yu, Wang, W., Pang, W., Xiao, Z., Jiang, Y., and Hong, Y., “Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation.”, J Alzheimers Dis, vol. 57, no. 2, pp. 475-482, 2017.
B. Xie, Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., and Xu, S., “DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.”, J Alzheimers Dis, vol. 58, no. 1, pp. 263-274, 2017.
B. Xie, Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., and Xu, S., “DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.”, J Alzheimers Dis, vol. 58, no. 1, pp. 263-274, 2017.
B. Xie, Xu, Y., Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., and Xu, S., “Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 391-401, 2017.
B. Xie, Xu, Y., Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., and Xu, S., “Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 391-401, 2017.
B. Xie, Xu, Y., Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., and Xu, S., “Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 391-401, 2017.
Y. Lian, Xiao, L. Dongxia, Zeng, F., Wu, X., Wang, Z., and Ren, H., “The Experiences of People with Dementia and Their Caregivers in Dementia Diagnosis.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1203-1211, 2017.
X. Zhuang, Chen, Y., Zhuang, X., Xing, T., Chen, T., Jiang, G., and Yang, X., “Impaired Center-Surround Suppression in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1101-1108, 2017.
B. Xie, Liu, Z., Jiang, L., Liu, W., Song, M., Zhang, Q., Zhang, R., Cui, D., Wang, X., and Xu, S., “Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.”, J Alzheimers Dis, vol. 55, no. 2, pp. 509-520, 2017.
B. Xie, Liu, Z., Jiang, L., Liu, W., Song, M., Zhang, Q., Zhang, R., Cui, D., Wang, X., and Xu, S., “Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.”, J Alzheimers Dis, vol. 55, no. 2, pp. 509-520, 2017.
F. Su, Shu, H., Ye, Q., Xie, C., Yuan, B., Zhang, Z., and Bai, F., “Integration of Multilocus Genetic Risk into the Default Mode Network Longitudinal Trajectory during the Alzheimer's Disease Process.”, J Alzheimers Dis, vol. 56, no. 2, pp. 491-507, 2017.
M. Anderson, Xu, F., Ou-Yang, M. - H., Davis, J., Van Nostrand, W. E., and Robinson, J. K., “Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1109-1121, 2017.
L. Li, Xu, S., Liu, L., Feng, R., Gong, Y., Zhao, X., Li, J., Cai, J., Feng, N., Wang, L., Wang, X., and Peng, Y., “Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1403-1417, 2017.
M. Javidnia, Hebron, M. L., Xin, Y., Kinney, N. G., and Moussa, C. E. - H., “Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.”, J Alzheimers Dis, vol. 60, no. 2, pp. 461-481, 2017.
C. Hu, Xu, J., Zeng, L., Li, T., Cui, M. - Z., and Xu, X., “Pen-2 and Presenilin are Sufficient to Catalyze Notch Processing.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1263-1269, 2017.
C. Hu, Xu, J., Zeng, L., Li, T., Cui, M. - Z., and Xu, X., “Pen-2 and Presenilin are Sufficient to Catalyze Notch Processing.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1263-1269, 2017.
L. Hao, Wang, X., Zhang, L., Xing, Y., Guo, Q., Hu, X., Mu, B., Chen, Y., Chen, G., Cao, J., Zhi, X., Liu, J., Li, X., Yang, L., Li, J., Du, W., Sun, Y., Wang, T., Liu, Z., Liu, Z., Zhao, X., Li, H., Yu, Y., Wang, X., Jia, J., and Han, Y., “Prevalence, Risk Factors, and Complaints Screening Tool Exploration of Subjective Cognitive Decline in a Large Cohort of the Chinese Population.”, J Alzheimers Dis, vol. 60, no. 2, pp. 371-388, 2017.
J. Chen, Zhang, T., Jiao, S., Zhou, X., Zhong, J., Wang, Y., Liu, J., Deng, J., Wang, S., and Xu, Z., “proBDNF Accelerates Brain Amyloid-β Deposition and Learning and Memory Impairment in APPswePS1dE9 Transgenic Mice.”, J Alzheimers Dis, vol. 59, no. 3, pp. 941-949, 2017.
L. Yu, Liu, Y., Yang, H., Zhu, X., Cao, X., Gao, J., Zhao, H., and Xu, Y., “PSD-93 Attenuates Amyloid-β-Mediated Cognitive Dysfunction by Promoting the Catabolism of Amyloid-β.”, J Alzheimers Dis, vol. 59, no. 3, pp. 913-927, 2017.
F. Xie and Peng, F., “Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.”, J Alzheimers Dis, vol. 59, no. 2, pp. 527-536, 2017.
L. Sun, Chen, K., Li, X., and Xiao, S., “Rapidly Progressive Frontotemporal Dementia Associated with MAPT Mutation G389R.”, J Alzheimers Dis, vol. 55, no. 2, pp. 777-785, 2017.
Y. Shen, Xia, Y., Meng, S., Lim, N. K. H., Wang, W., and Huang, F., “SH2B1 is Involved in the Accumulation of Amyloid-β42 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 835-847, 2017.

Pages